Summary
Updated Aug 31, 2026
Ryan D. Maynard is Director of IOVANCE BIOTHERAPEUTICS, INC. (IOVA). 3 SEC Form 4 filings on record going back to 2024, most recently on 18 June 2026. Most recent open-market trade: sold $503K of IOVA on 14 November 2024. Lifetime open-market sales: $503K.
Recent Transactions
2Every recent SEC Form 4 transaction Ryan D. Maynard has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Ryan D. Maynard's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Jeffrey M. Leiden - $60.94M of VRTX open-market activity in the last 12 months
- Vivek Ramaswamy - $60.40M of ROIV open-market activity in the last 12 months
- David Cordani - $60.11M of CI open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $60.00M of KOD open-market activity in the last 12 months
- Deep Track Biotechnology Master Fund, Ltd. - $60.00M of LBRX open-market activity in the last 12 months
- AI DMI LLC - $59.87M of IRON open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Ryan D. Maynard?
Ryan D. Maynard is a corporate insider, tracked as Director of IOVANCE BIOTHERAPEUTICS, INC. (IOVA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ryan D. Maynard submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Ryan D. Maynard been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($503K) across all tracked filings.
Where can I see all of Ryan D. Maynard's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Ryan D. Maynard and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
